Ten adults participated in the study which consisted of four experimental periods each lasting 2 weeks, during each of which subjects were assigned to one of four gum-chewing regimens: no gum, sucrose gum, sorbitol gum and xylitol gum. At the start and end of each test period unstimulated and stimulated salivary flow rates were determined. At the end of each test period the acidogenic potential of 48-hour dental plaque was measured using a Beetrode pH microelectrode. No statistically significant (p < 0.05) effect on salivary flow rate was observed. The xylitol chewing gum regimen resulted in significantly higher plaque pH than no gum, sucrose gum and sorbitol gum at 2,10, 20, 30 and 60 min following a 10% sucrose rinse. In addition, xylitol gum regimen exhibited a significantly higher minimum pH and smaller area of the curve below pH 6. The results suggest that the regular use of xylitol-sweetened gum may serve to reduce the acidogenic potential of dental plaque.

Keywords:
Plaque pH, Salivary flow rate, Sorbitol gum, Xylitol gum
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.